{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:51:44Z","timestamp":1783338704980,"version":"3.54.6"},"reference-count":46,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.exer.2013.04.007","type":"journal-article","created":{"date-parts":[[2013,4,18]],"date-time":"2013-04-18T11:50:40Z","timestamp":1366285840000},"page":"29-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Biodegradable nanoparticles for controlled subconjunctival delivery of latanoprost acid: In\u00a0vitro and in\u00a0vivo evaluation. Preliminary results"],"prefix":"10.1016","volume":"112","author":[{"given":"Athanassios","family":"Giarmoukakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Labiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haris","family":"Sideroudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zinovia","family":"Tsimali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nefeli","family":"Koutsospyrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Avgoustakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilios","family":"Kozobolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.exer.2013.04.007_bib1","first-page":"940","article-title":"Comparison of three tonometers for measuring intraocular pressure in rabbits","volume":"37","author":"Abrams","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2013.04.007_bib2","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1211\/0022357044896","article-title":"Development of a topical niosomal preparation of acetazolamide: preparation and evaluation","volume":"56","author":"Aggarwal","year":"2004","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.exer.2013.04.007_bib3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2004.10.026","article-title":"Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system","volume":"290","author":"Aggarwal","year":"2005","journal-title":"Int. J. Pharm."},{"issue":"10","key":"10.1016\/j.exer.2013.04.007_bib4","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1002\/jps.10209","article-title":"Soft contact lenses capable of sustained delivery of timolol","volume":"91","author":"Alvarez-Lorenzo","year":"2002","journal-title":"J.\u00a0Pharm. Sci."},{"issue":"3","key":"10.1016\/j.exer.2013.04.007_bib5","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1208\/s12249-009-9268-4","article-title":"Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride","volume":"10","author":"Ammar","year":"2009","journal-title":"AAPS PharmSciTech"},{"issue":"12","key":"10.1016\/j.exer.2013.04.007_bib6","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1211\/jpp.57.12.0005","article-title":"Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration","volume":"57","author":"Amrite","year":"2005","journal-title":"J.\u00a0Pharm. Pharmacol."},{"issue":"11","key":"10.1016\/j.exer.2013.04.007_bib7","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1080\/00032710600755330","article-title":"High-performance liquid chromatography determination of latanoprost in pharmaceutical formulations using UV detection","volume":"39","author":"Ashfaq","year":"2006","journal-title":"Anal. Lett."},{"issue":"8","key":"10.1016\/j.exer.2013.04.007_bib8","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1600-0420.2007.00980.x","article-title":"Incidence and prevalence of pseudoexfoliations and open-angle glaucoma in northern Sweden: II. Results after 21 years of follow-up","volume":"85","author":"Astr\u00f6m","year":"2007","journal-title":"Acta Ophthalmol. Scand."},{"issue":"8","key":"10.1016\/j.exer.2013.04.007_bib9","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1080\/02713680903017500","article-title":"Sustained release and permeation of timolol from surface-modified solid lipid nanoparticles through bioengineered human cornea","volume":"34","author":"Attama","year":"2009","journal-title":"Curr. Eye Res."},{"issue":"4","key":"10.1016\/j.exer.2013.04.007_bib10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2174\/1567201043334605","article-title":"Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery","volume":"1","author":"Avgoustakis","year":"2004","journal-title":"Curr. Drug Deliv."},{"issue":"4","key":"10.1016\/j.exer.2013.04.007_bib11","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1039\/b9nr00253g","article-title":"Preparation, stability and cytocompatibility of magnetic\/PLA-PEG hybrids","volume":"2","author":"Bakandritsos","year":"2010","journal-title":"Nanoscale"},{"key":"10.1016\/j.exer.2013.04.007_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0952-3278(94)90139-2","article-title":"Corneal permeability to and ocular metabolism of phenyl substituted prostaglandin esters in\u00a0vitro","volume":"50","author":"Basu","year":"1994","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"1","key":"10.1016\/j.exer.2013.04.007_bib13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/02652040802095250","article-title":"Sustained delivery of timolol maleate from poly(lactic-co-glycolic acid)\/poly(lactic acid) microspheres for over 3 months","volume":"26","author":"Bertram","year":"2009","journal-title":"J.\u00a0Microencapsul."},{"key":"10.1016\/j.exer.2013.04.007_bib14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1600-0420.1997.tb00155.x","article-title":"Blindness in glaucoma patients","volume":"75","author":"Blomdahl","year":"1997","journal-title":"Acta Ophthalmol. Scand."},{"key":"10.1016\/j.exer.2013.04.007_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jconrel.2003.10.015","article-title":"Effective protein release from PEG\/PLA nano-particles produced by compressed gas anti-solvent precipitation techniques","volume":"94","author":"Caliceti","year":"2004","journal-title":"J.\u00a0Control Release"},{"issue":"5","key":"10.1016\/j.exer.2013.04.007_bib16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bjo.2006.110155","article-title":"Levels of bimatoprost acid in the aqueous humour after bimatoprost treatment of patients with cataract","volume":"91","author":"Cantor","year":"2007","journal-title":"Br. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.exer.2013.04.007_bib17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1248\/yakushi.130.419","article-title":"Methazolamide calcium phosphate nanoparticles in an ocular delivery system","volume":"130","author":"Chen","year":"2010","journal-title":"Yakugaku Zasshi"},{"issue":"3","key":"10.1016\/j.exer.2013.04.007_bib18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/jop.1996.12.245","article-title":"Ocular mini-tablets for controlled release of timolol: evaluation in rabbits","volume":"12","author":"Chetoni","year":"1996","journal-title":"J.\u00a0Ocul. Pharmacol. Ther."},{"issue":"Suppl. 1","key":"10.1016\/j.exer.2013.04.007_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.survophthal.2008.08.006","article-title":"Risk factors for glaucoma onset and progression","volume":"53","author":"Coleman","year":"2008","journal-title":"Surv. Ophthalmol."},{"issue":"6","key":"10.1016\/j.exer.2013.04.007_bib20","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1023\/A:1018826103261","article-title":"Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles: influence on physical stability and in\u00a0vitro cell uptake","volume":"16","author":"De Jaeghere","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.exer.2013.04.007_bib21","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1001\/archopht.122.4.532","article-title":"Prevalence of open-angle glaucoma among adults in the United States","volume":"122","author":"Friedman","year":"2004","journal-title":"Arch. Ophthalmol."},{"issue":"1","key":"10.1016\/j.exer.2013.04.007_bib22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1755-3768.2009.01663.x","article-title":"A\u00a0randomized, 36-month, post-marketing efficacy and tolerability study in Sweden and Finland of latanoprost versus non-prostaglandin therapy in patients with glaucoma or ocular hypertension","volume":"88","author":"Fristr\u00f6m","year":"2010","journal-title":"Acta Ophthalmol."},{"issue":"5","key":"10.1016\/j.exer.2013.04.007_bib23","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s11095-008-9694-0","article-title":"Recent perspectives in ocular drug delivery","volume":"26","author":"Gaudana","year":"2009","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.exer.2013.04.007_bib24","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J."},{"issue":"1","key":"10.1016\/j.exer.2013.04.007_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2006.12.017","article-title":"Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells","volume":"67","author":"Gryparis","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.exer.2013.04.007_bib26","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2105\/AJPH.83.5.711","article-title":"Treatment for glaucoma \u2013 adherence by the elderly","volume":"83","author":"Gurwitz","year":"1993","journal-title":"Am. J. Public Health"},{"issue":"4","key":"10.1016\/j.exer.2013.04.007_bib27","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/jbm.a.31942","article-title":"Biodegradable fumarate-based drug-delivery systems for ophthalmic applications","volume":"88","author":"Hacker","year":"2009","journal-title":"J.\u00a0Biomed. Mater. Res. A"},{"issue":"4","key":"10.1016\/j.exer.2013.04.007_bib28","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1755-3768.2010.02050.x","article-title":"Adherence with brimonidine in patients with glaucoma aware and not aware of electronic monitoring","volume":"89","author":"Hermann","year":"2011","journal-title":"Acta Ophthalmol."},{"issue":"2","key":"10.1016\/j.exer.2013.04.007_bib29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00061198-200004000-00003","article-title":"Crete, Greece glaucoma study","volume":"9","author":"Kozobolis","year":"2000","journal-title":"J.\u00a0Glaucoma"},{"key":"10.1016\/j.exer.2013.04.007_bib30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jconrel.2003.10.012","article-title":"Incorporation and release behavior of hydrophobic drug in functionalized poly(D, L-lactide)-blockpoly(ethylene oxide) micelles","volume":"94","author":"Lee","year":"2004","journal-title":"J.\u00a0Control Release"},{"issue":"10","key":"10.1016\/j.exer.2013.04.007_bib31","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/mabi.200600101","article-title":"Amphiphilic poly(D, L-lactic acid)\/poly(ethylene glycol)\/poly(D, L-lactic acid) nanogels for controlled release of hydrophobic drugs","volume":"6","author":"Lee","year":"2006","journal-title":"Macromol. Biosci."},{"issue":"2","key":"10.1016\/j.exer.2013.04.007_bib32","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1208\/s12249-011-9643-9","article-title":"Nanovesicular formulation of brimonidine tartrate for the management of glaucoma: in\u00a0vitro and in\u00a0vivo evaluation","volume":"12","author":"Maiti","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.exer.2013.04.007_bib33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.preteyeres.2004.08.003","article-title":"Understanding mechanisms of pressure-induced optic nerve damage","volume":"24","author":"Morrison","year":"2005","journal-title":"Prog. Retin. Eye Res."},{"issue":"9","key":"10.1016\/j.exer.2013.04.007_bib34","doi-asserted-by":"crossref","first-page":"e24513","DOI":"10.1371\/journal.pone.0024513","article-title":"Sustained release of an anti-glaucoma drug: demonstration of efficacy of a liposomal formulation in the rabbit eye","volume":"6","author":"Natarajan","year":"2011","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.exer.2013.04.007_bib35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijpharm.2011.05.047","article-title":"In\u00a0vitro and in\u00a0vivo evaluation of an intraocular implant for glaucoma treatment","volume":"415","author":"Natu","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.exer.2013.04.007_bib36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ophtha.2008.09.004","article-title":"Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study","volume":"116","author":"Okeke","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2013.04.007_bib37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2165\/00002512-199609050-00007","article-title":"Latanoprost. A review of its pharmacological properties, and tolerability in the management of primary open-angle glaucoma and ocular hypertension","volume":"9","author":"Patel","year":"1996","journal-title":"Drugs Aging"},{"issue":"11","key":"10.1016\/j.exer.2013.04.007_bib38","first-page":"844","article-title":"Global data on visual impairment in the year 2002","volume":"82","author":"Resnikoff","year":"2004","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.exer.2013.04.007_bib39","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.exer.2006.10.008","article-title":"Glaucomatous outflow pathway and oxidative stress","volume":"84","author":"Sacca","year":"2007","journal-title":"Exp. Eye Res."},{"issue":"Suppl. 1","key":"10.1016\/j.exer.2013.04.007_bib40","first-page":"146","article-title":"The general pharmacokinetics and metabolism of latanoprost, a new antiglaucoma drug","volume":"59","author":"Sjoquist","year":"1994","journal-title":"Exp. Eye Res."},{"issue":"Suppl. 1","key":"10.1016\/j.exer.2013.04.007_bib41","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0039-6257(02)00302-8","article-title":"Ocular and systemic pharmacokinetics of latanoprost in humans","volume":"47","author":"Sj\u00f6quist","year":"2002","journal-title":"Surv. Ophthalmol."},{"issue":"1","key":"10.1016\/j.exer.2013.04.007_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2011.05.033","article-title":"Ocular surface disease and quality of life in patients with glaucoma","volume":"153","author":"Skalicky","year":"2012","journal-title":"Am. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.exer.2013.04.007_bib43","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/jbm.820190315","article-title":"Biodegradation of and tissue reaction to 50:50 poly(DL-lactide-co-glycolide) microcapsules","volume":"19","author":"Visscher","year":"1985","journal-title":"J.\u00a0Biomed. Mater. Res."},{"issue":"4","key":"10.1016\/j.exer.2013.04.007_bib44","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3109\/10611860903450023","article-title":"Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation","volume":"18","author":"Wadhwa","year":"2010","journal-title":"J.\u00a0Drug Target"},{"key":"10.1016\/j.exer.2013.04.007_bib45","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0161-6420(96)30750-1","article-title":"A\u00a0six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension","volume":"103","author":"Watson","year":"1996","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.exer.2013.04.007_bib46","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/00061198-200412000-00005","article-title":"A\u00a0pilot study of a system for grading of drainage blebs after glaucoma surgery","volume":"13","author":"Wells","year":"2004","journal-title":"J.\u00a0Glaucoma"}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448351300095X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448351300095X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T17:21:59Z","timestamp":1539710519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448351300095X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":46,"alternative-id":["S001448351300095X"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2013.04.007","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biodegradable nanoparticles for controlled subconjunctival delivery of latanoprost acid: In\u00a0vitro and in\u00a0vivo evaluation. Preliminary results","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2013.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}